ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2010 | 9.04 Million USD | -25.63% |
| 2009 | 12.15 Million USD | 57060.18% |
| 2008 | 21.26 Thousand USD | 136.74% |
| 2007 | -57.88 Thousand USD | -253.52% |
| 2006 | 37.7 Thousand USD | 85.42% |
| 2005 | 20.33 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2011 Q1 | 14.16 Million USD | 56.72% |
| 2011 Q3 | 11.55 Million USD | -7.38% |
| 2011 Q2 | 12.47 Million USD | -11.92% |
| 2010 Q3 | 12.43 Million USD | -7.07% |
| 2010 Q2 | 13.38 Million USD | 12.58% |
| 2010 FY | 9.04 Million USD | -25.63% |
| 2010 Q1 | 11.88 Million USD | -2.2% |
| 2010 Q4 | 9.04 Million USD | -27.32% |
| 2009 Q2 | -194.83 Thousand USD | -821.12% |
| 2009 Q4 | 12.15 Million USD | 7.1% |
| 2009 FY | 12.15 Million USD | 57060.18% |
| 2009 Q1 | 27.01 Thousand USD | 27.05% |
| 2009 Q3 | 11.34 Million USD | 5925.35% |
| 2008 FY | 21.26 Thousand USD | 136.74% |
| 2008 Q3 | 20.77 Thousand USD | -18.67% |
| 2008 Q4 | 21.26 Thousand USD | 2.34% |
| 2008 Q2 | 25.55 Thousand USD | 6.86% |
| 2008 Q1 | 23.91 Thousand USD | 141.31% |
| 2007 FY | -57.88 Thousand USD | -253.52% |
| 2007 Q2 | 25.81 Thousand USD | 44.86% |
| 2007 Q3 | 42.65 Thousand USD | 65.22% |
| 2007 Q4 | -57.88 Thousand USD | -235.7% |
| 2007 Q1 | 17.82 Thousand USD | -52.73% |
| 2006 Q4 | 37.7 Thousand USD | 0.0% |
| 2006 FY | 37.7 Thousand USD | 85.42% |
| 2005 FY | 20.33 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 690179.008% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -60.047% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 78.875% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 3721.519% |
| Rebus Holdings, Inc. | 305 Thousand USD | -2863.946% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 243.39% |
| Qrons Inc. | 351.42 Thousand USD | -2472.379% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -1352.532% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 79.187% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 44396.526% |
| Skye Bioscience, Inc. | -5.72 Million USD | 258.004% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 42.65% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -119.524% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -2149.61% |
| SQZ Biotechnologies Company | -36.23 Million USD | 124.946% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -303.171% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -874.997% |
| Mesoblast Limited | 55.85 Million USD | 83.816% |
| Marizyme, Inc. | 18.56 Million USD | 51.317% |
| Genus plc | 190.6 Million USD | 95.257% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -304.325% |
| Pharming Group N.V. | 109.8 Million USD | 91.767% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -950.872% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -644.717% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -1229.417% |
| ContraFect Corporation | -6.02 Million USD | 250.017% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -6614.277% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -682.396% |
| IMV Inc. | 7.67 Million USD | -17.854% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -64.308% |
| MultiCell Technologies, Inc. | 90.04 USD | -10039921.102% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 1331.649% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 30.171% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -560.835% |
| Q BioMed Inc. | 4.06 Million USD | -122.661% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 70.413% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -797.082% |
| Biomind Labs Inc. | 711.4 Thousand USD | -1170.735% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 85.069% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -352.139% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 29.411% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -2413.145% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -6366.221% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -45402.768% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -310.541% |
| GB Sciences, Inc. | 1.74 Million USD | -417.367% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 5018.73% |
| HST Global, Inc. | 96.79 Thousand USD | -9239.555% |
| CSL Limited | 10.52 Billion USD | 99.914% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -4283.749% |
| Halberd Corporation | 144.72 Thousand USD | -6146.526% |
| Enzolytics Inc. | 981.65 Thousand USD | -820.896% |
| Agentix Corp. | 37.63 Thousand USD | -23922.84% |
| Resverlogix Corp. | 6.45 Million USD | -40.134% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 1443.067% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.446% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 119.229% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -27.847% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -233.751% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 202.264% |
| AVAX Technologies, Inc. | -5.9 Million USD | 253.138% |
| Zenith Capital Corp. | 10.06 Thousand USD | -89725.467% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.852% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -4410.275% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -278.873% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -5395.161% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 49450.557% |
| Kadimastem Ltd | -253.1 Thousand USD | 3671.696% |
| Helix BioMedix, Inc. | -2.57 Million USD | 451.748% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 55.415% |
| BioStem Technologies, Inc. | 4.47 Million USD | -102.147% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -4391.854% |
| LadRx Corporation | -2.03 Million USD | 543.907% |
| Cell Source, Inc. | 9.23 Million USD | 2.079% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1323.253% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1323.253% |
| NovAccess Global Inc. | 2.17 Million USD | -314.973% |
| Affymax, Inc. | -5.59 Million USD | 261.516% |
| Itoco Inc. | 228.3 Thousand USD | -3859.631% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -6547.622% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -82.369% |
| Mobile Lads Corp. | 484.23 Thousand USD | -1766.881% |
| CytoDyn Inc. | 20.26 Million USD | 55.384% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 1397323.338% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 97636.722% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -17.312% |
| SYBLEU INC | 473.71 Thousand USD | -1808.332% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -102.827% |
| International Stem Cell Corporation | 2.59 Million USD | -249.036% |
| Bioxytran, Inc. | 1.89 Million USD | -376.063% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -14384.218% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -314.509% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -163.251% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -5.694% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -1070.069% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 823.203% |
| Neutra Corp. | 52.18 Thousand USD | -17222.389% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 463.199% |
| PureTech Health plc | -167.19 Million USD | 105.407% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 3791.196% |
| IXICO plc | -4.44 Million USD | 303.394% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 31.613% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 83.519% |
| CSL Limited | 10.52 Billion USD | 99.914% |
| Cellectis S.A. | -43.81 Million USD | 120.63% |